A number of research firms have changed their ratings and price targets for Intercept Pharmaceuticals (NASDAQ: ICPT): 3/8/2021 – Intercept Pharmaceuticals had its price target lowered by analysts at Wedbush from $106.00 to $88.00. They now have an “outperform” rating on the stock. 3/8/2021 – Intercept Pharmaceuticals had its price target lowered by analysts at […]
